Gene · 6335
Papers3,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Follistatin drives neuropathic pain in mice through IGF1R signaling in nociceptive neurons. | Sci Transl Med | 2024 | 39413164 | PubTator, text mining | PubMed |
| Congenital Insensitivity to Pain: A Case Study of a Rare Genetic Disorder. | Cureus | 2024 | 39403642 | PubTator, text mining | PubMed |
| Interplay of Nav1.8 and Nav1.7 channels drives neuronal hyperexcitability in neuropathic pain. | J Gen Physiol | 2024 | 39378238 | PubTator, text mining | PubMed |
| Comparison of Nocifensive Behavior in NaV1.7-, NaV1.8-, and NaV1.9-Channelrhodopsin-2 Mice by Selective Optogenetic Activation of Targeted Sodium Channel Subtype-Expressing Afferents. | J Neurosci Res | 2024 | 39364619 | PubTator, text mining | PubMed |
| Biologically active franchetine-type diterpenoid alkaloids: Isolation, synthesis, anti-inflammatory, agalgesic activities, and molecular docking. | Bioorg Chem | 2024 | 39332071 | PubTator, text mining | PubMed |
| Autoantigens of Small Nerve Fibers and Human Coronavirus Antigens: Is There a Possibility for Molecular Mimicry? | Curr Microbiol | 2024 | 39297982 | PubTator, text mining | PubMed |
| Whole genome sequencing in adults with clinical hallmarks of hypophosphatasia negative for ALPL variants. | Mol Biol Rep | 2024 | 39276275 | PubTator, text mining | PubMed |
| A venom peptide-induced NaV channel modulation mechanism involving the interplay between fixed channel charges and ionic gradients. | J Biol Chem | 2024 | 39260690 | PubTator, text mining | PubMed |
| Optimizing Nav1.7-Targeted Analgesics: Revealing Off-Target Effects of Spider Venom-Derived Peptide Toxins and Engineering Strategies for Improvement. | Adv Sci (Weinh) | 2024 | 39248322 | PubTator, text mining | PubMed |
| An artificial intelligence accelerated virtual screening platform for drug discovery. | Nat Commun | 2024 | 39237523 | PubTator, text mining | PubMed |
| A Novel Antigen Design Strategy to Isolate Single-Domain Antibodies that Target Human Nav1.7 and Reduce Pain in Animal Models. | Adv Sci (Weinh) | 2024 | 39206821 | PubTator, text mining | PubMed |
| Human pain channelopathies. | Handb Clin Neurol | 2024 | 39174256 | PubTator, text mining | PubMed |
| Optical genome mapping identifies a homozygous deletion in the non-coding region of the SCN9A gene in individuals from the same family with congenital insensitivity to pain. | Front Genet | 2024 | 39156962 | PubTator, text mining | PubMed |
| Spider and scorpion knottins targeting voltage-gated sodium ion channels in pain signaling. | Biochem Pharmacol | 2024 | 39102991 | PubTator, text mining | PubMed |
| Depletion of membrane cholesterol modifies structure, dynamic and activation of Nav1.7. | Int J Biol Macromol | 2024 | 39097041 | PubTator, text mining | PubMed |
| Therapeutic targeting of voltage-gated sodium channel NaV1.7 for cancer metastasis. | Front Pharmacol | 2024 | 39045054 | PubTator, text mining | PubMed |
| Evolution of ion channels in cetaceans: a natural experiment in the tree of life. | Sci Rep | 2024 | 39043711 | PubTator, text mining | PubMed |
| Genetic Analysis of SCN11A, SCN10A, and SCN9A in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria. | Int J Mol Sci | 2024 | 38999942 | PubTator, text mining | PubMed |
| Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management. | Bioorg Chem | 2024 | 38971095 | PubTator, text mining | PubMed |
| Effects of pH on opioid receptor activation and implications for drug design. | Biophys J | 2024 | 38970252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6335/papers?page=12